Aditxt, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number
Aditxt, Inc. (ADTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number of 170 shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber · last filed 2023-11-14
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 9 month 170.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 9 month |
|---|---|
| 2023-09-30 | 170.00 shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |